Effects of histone deacetylase inhibitor FR901228 on the expression level of telomerase reverse transcriptase in oral cancer

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-004-0976-x ◽

2005 ◽

Vol 56 (1) ◽

pp. 22-28 ◽

Author(s):

Jun Murakami ◽

Jun-ichi Asaumi ◽

Noriko Kawai ◽

Hidetsugu Tsujigiwa ◽

Yoshinobu Yanagi ◽

...

Keyword(s):

Oral Cancer ◽

Reverse Transcriptase ◽

Histone Deacetylase ◽

Histone Deacetylase Inhibitor ◽

Expression Level ◽

Telomerase Reverse Transcriptase ◽

Deacetylase Inhibitor

Download Full-text

The Histone Deacetylase Inhibitor Trichostatin A Derepresses the Telomerase Reverse Transcriptase (hTERT) Gene in Human Cells

Experimental Cell Research ◽

10.1006/excr.2001.5462 ◽

2002 ◽

Vol 274 (1) ◽

pp. 25-34 ◽

Author(s):

Mi Hou ◽

XiongBiao Wang ◽

Nikita Popov ◽

Anju Zhang ◽

Xiaoyan Zhao ◽

...

Keyword(s):

Reverse Transcriptase ◽

Histone Deacetylase ◽

Histone Deacetylase Inhibitor ◽

Trichostatin A ◽

Human Cells ◽

Telomerase Reverse Transcriptase ◽

Deacetylase Inhibitor ◽

Histone Deacetylase Inhibitor Trichostatin

Download Full-text

Epigenetic therapy using the histone deacetylase inhibitor for increasing therapeutic gain in oral cancer: prevention of radiation-induced oral mucositis and inhibition of chemical-induced oral carcinogenesis

Carcinogenesis ◽

10.1093/carcin/bgp079 ◽

2009 ◽

Vol 30 (8) ◽

pp. 1387-1397 ◽

Author(s):

Y.-L. Chung ◽

M.-Y. Lee ◽

N. N.M. Pui

Keyword(s):

Oral Cancer ◽

Cancer Prevention ◽

Histone Deacetylase ◽

Oral Mucositis ◽

Histone Deacetylase Inhibitor ◽

Epigenetic Therapy ◽

Oral Carcinogenesis ◽

Deacetylase Inhibitor ◽

Therapeutic Gain ◽

Radiation Induced

Download Full-text

The Effect of Histone Deacetylase Inhibitor on the Expression Level of Glucococrticoid Receptor in Rat Forebrain under Hypoxia

Cell and Tissue Biology ◽

10.1134/s1990519x19020044 ◽

2019 ◽

Vol 13 (2) ◽

pp. 79-84

Author(s):

A. V. Churilova ◽

T. S. Gluschenko ◽

E. A. Rybnikova ◽

M. O. Samoilov

Keyword(s):

Histone Deacetylase ◽

Histone Deacetylase Inhibitor ◽

Expression Level ◽

Deacetylase Inhibitor ◽

Download Full-text

Effects of demethylating agent 5-aza-2′-deoxycytidine and histone deacetylase inhibitor FR901228 on maspin gene expression in oral cancer cell lines

Oral Oncology ◽

10.1016/j.oraloncology.2003.12.008 ◽

2004 ◽

Vol 40 (6) ◽

pp. 597-603 ◽

Author(s):

J Murakami

Keyword(s):

Gene Expression ◽

Oral Cancer ◽

Histone Deacetylase ◽

Cancer Cell ◽

Histone Deacetylase Inhibitor ◽

Cancer Cell Lines ◽

Demethylating Agent ◽

Oral Cancer Cell ◽

Deacetylase Inhibitor

Download Full-text

147: Low Concentration of a Histone Deacetylase Inhibitor, Depsipeptide (FK228), Enhances the Effect of Gemcitabine and Docetaxel in Hormone Refractory Prostate Cancer Cells

The Journal of Urology ◽

10.1016/s0022-5347(18)30412-9 ◽

2007 ◽

Vol 177 (4S) ◽

pp. 50-51

Author(s):

Masatoshi Kanzaki ◽

Hideaki Kakinuma ◽

Teruaki Kumazawa ◽

Takamitsu Inoue ◽

Mitsuru Saito ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Cells ◽

Histone Deacetylase ◽

Histone Deacetylase Inhibitor ◽

Hormone Refractory Prostate Cancer ◽

Prostate Cancer Cells ◽

Low Concentration ◽

Deacetylase Inhibitor ◽

Hormone Refractory

Download Full-text

Structure-activity investigations of Santacruzamate A, a potent histone deacetylase inhibitor isolated from a Panamanian cyanobacterium

Planta Medica ◽

10.1055/s-0032-1320383 ◽

2012 ◽

Vol 78 (11) ◽

Author(s):

CM Pavlik ◽

MJ Balunas

Keyword(s):

Histone Deacetylase ◽

Histone Deacetylase Inhibitor ◽

Structure Activity ◽

Deacetylase Inhibitor

Download Full-text

Induction of apoptosis in hepatocellular carcinoma by a novel combination of histone deacetylase inhibitor LBH589

10.1055/s-0039-3402242 ◽

2020 ◽

Author(s):

P Mester ◽

E Aschenbrenner ◽

C Kunst ◽

K Gülow ◽

M Müller-Schilling

Keyword(s):

Hepatocellular Carcinoma ◽

Histone Deacetylase ◽

Histone Deacetylase Inhibitor ◽

Deacetylase Inhibitor ◽

Induction Of Apoptosis

Download Full-text

Induction of Apoptosis and Chemosensitization by the Histone Deacetylase Inhibitor Trichostatin in Hepatocellular Carcinoma Cells: Molecular Analysis and RKIP Levels

Forum on Immunopathological Diseases and Therapeutics ◽

10.1615/forumimmundisther.v2.i2.40 ◽

2011 ◽

Vol 2 (2) ◽

pp. 127-135 ◽

Author(s):

Luigi Inguglia ◽

Monica Notarbartolo ◽

Paola Poma ◽

Manuela Labbozzetta ◽

Natale D'Alessandro

Keyword(s):

Hepatocellular Carcinoma ◽

Histone Deacetylase ◽

Molecular Analysis ◽

Histone Deacetylase Inhibitor ◽

Carcinoma Cells ◽

Hepatocellular Carcinoma Cells ◽

Deacetylase Inhibitor ◽

Histone Deacetylase Inhibitor Trichostatin ◽

Induction Of Apoptosis

Download Full-text

Faculty Opinions recommendation of Suppression of oxidative stress by β-hydroxybutyrate, an endogenous histone deacetylase inhibitor.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717972967.793469769 ◽

2013 ◽

Author(s):

Wendy Boss

Keyword(s):

Oxidative Stress ◽

Histone Deacetylase ◽

Histone Deacetylase Inhibitor ◽

Deacetylase Inhibitor

Download Full-text

Faculty of 1000 evaluation for A phase I study of histone deacetylase inhibitor, pracinostat (SB939), in pediatric patients with refractory solid tumors: IND203 a trial of the NCIC IND program/C17 pediatric phase I consortium.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.718050520.793482822 ◽

2013 ◽

Author(s):

Burton Eisenberg

Keyword(s):

Phase I ◽

Solid Tumors ◽

Histone Deacetylase ◽

Histone Deacetylase Inhibitor ◽

Phase I Study ◽

Pediatric Patients ◽

Deacetylase Inhibitor

Download Full-text